Parasite Plasticity in South Asian Malaria
南亚疟疾中的寄生虫可塑性
基本信息
- 批准号:8306807
- 负责人:
- 金额:$ 24.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AfricaAllelesAntigensAntimalarialsAreaAsiaAsiansB-LymphocytesBiologicalBiological AssayCambodiaCentral AmericaChemicalsChloroquineChloroquine resistanceClinicalComplexControlled StudyCountryDataDihydroorotate Dehydrogenase InhibitorDihydropteroate SynthaseDiseaseDrug resistanceEpidemiologyErythrocytesEventEvolutionFarnesyl Transferase InhibitorFrequenciesGene DuplicationGene TransferGenesGeneticGenetic CrossesGenetic PolymorphismGenomeGenomicsGenotypeGeographic LocationsGeographyGoalsHost DefenseHumanImmuneImmune responseImmunoglobulin Variable RegionIn VitroIndiaIndividualLaboratoriesLife Cycle StagesLinkLinkage DisequilibriumLiverMalariaMembrane ProteinsMethodologyMethodsMolecularMutagenesisMutationMyanmarOrganPapua New GuineaParasitesPathogenesisPatientsPharmaceutical PreparationsPhenotypePlasmodium falciparumPoint MutationPopulationPrevalencePricePrimatesPropertyRecording of previous eventsResearchResistanceResistance developmentRiskRunningSamplingSeverity of illnessSiteSouth AsianSoutheastern AsiaSporozoitesStretchingSystems DevelopmentTestingThailandThymidylate Synthase InhibitorTimeTreatment FailureVariantVirulentWalkersWorkbasedrug qualitygenome wide association studyimprovedinterestnon-drugnovelpreferencepressureprogramsresearch studyresistance mechanismsample collectionthymidylate synthase-dihydrofolate reductasetooltraitvector
项目摘要
Strains of P. falciparum from different regions ofthe worid have varying capacifies to acquire resistance to new
antimalarials. Founder events leading to clinical drug resistance against tradifional antimalarials were rare, yet,
when they occurred, they occurred in specific regions ofthe worid such as SoutheastAsia (Thailand), Central
America (Columbia), and Papua New Guinea. The Project Director's (PD) lab has shown that the capacity to
acquire resistance to new antimalarials in vitro is best related to parasite strains originating in countries with
high level of drug resistance. However, these studies were performed with laboratory parasite clones adapted
to culture two decades ago. and have long, varied histories in individual research labs.
The goal of Project 2 is to determine if parasites in South Asia can acquire resistance to experimental
anfimalarials at extraordinary rates, and to establish their genotypes. There is a unique opportunity here to
study origins of complex polymorphisms associated with resistance in parasites, both because ofthe proximity
of South Asia to Myanmar and Cambodia, and due to some major initiafives to eradicate malaria in defined
regions of India.
In this project, exisfing and newly isolated P. falciparum from South Asian pafients will be phenotyped
for the Accelerated Resistance to Mulfiple Drugs (or ARMD) trait based on their capacities to acquire
resistance to novel, well-characterized anfimalarials through in vitro selecfion experiments. The methodologies
for in vitro selecfions were developed, and are well established, in the PD's lab. Using 3 different chemical
probes, the parasites will be characterized with respect to frequencies of resistance, rates of point mutations,
and frequency of amplification/deletion events Similarities and differences in resistance mechanisms will be
compared between established lab clones from around the worid and newly culture-adapted field strains from
South Asia.
来自世界不同地区的恶性疟原虫菌株对新的病毒具有不同的抗药性。
抗疟疾药。创始人事件导致对传统抗疟疾药物的临床耐药性是罕见的,然而,
当它们发生时,它们发生在世界的特定区域,如东南亚(泰国)、中部
美洲(哥伦比亚)和巴布亚新几内亚。项目总监(PD)的实验室已经表明,
在体外获得对新抗疟疾药物的耐药性与起源于以下国家的寄生虫菌株最相关
抗药性很强。然而,这些研究是在实验室寄生虫克隆的情况下进行的
二十年前的文化。在各个研究实验室有着悠久的、不同的历史。
项目2的目标是确定南亚的寄生虫是否能够获得对实验性寄生虫的抵抗力
疟疾以超乎寻常的速度传播,并确定它们的基因类型。这里有一个独特的机会来
研究与寄生虫耐药性相关的复杂多态的起源,两者都是因为邻近
从南亚到缅甸和柬埔寨,并由于在确定的消除疟疾方面的一些重大倡议
印度的一些地区。
在这个项目中,将对南亚性行为者中现存的和新分离的恶性疟原虫进行表型分析。
基于获得能力的多重药物(或ARMD)加速耐药特性
通过体外选择实验对新的、特征良好的抗疟药产生抗药性。方法论
因为在体外,PD的实验室已经开发出了选择素,并且已经得到了很好的证实。使用3种不同的化学物质
对于探针,寄生虫将根据抗性频率、点突变率、
而扩增/缺失事件发生的频率相同和不同的抗性机制将是
来自世界各地的已建立的实验室克隆与来自中国的新的培养适应的野外菌株的比较
南亚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PRADIPSINH K. RATHOD其他文献
PRADIPSINH K. RATHOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PRADIPSINH K. RATHOD', 18)}}的其他基金
High Throughput Screens for Malaria Topoisomerases
疟疾拓扑异构酶的高通量筛选
- 批准号:
8217269 - 财政年份:2011
- 资助金额:
$ 24.71万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 24.71万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 24.71万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 24.71万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 24.71万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 24.71万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 24.71万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 24.71万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 24.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 24.71万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 24.71万 - 项目类别: